The Washington, D.C.-based life sciences company sold roughly 2.38 billion Swiss francs of notes in seven parts to help finance its
The deal is the largest in what’s considered the traditional private-placement market of raising capital directly from large institutional investors, according to
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
